FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088319 [Registered on: 05/06/2025] Trial Registered Prospectively
Last Modified On: 02/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to know the skeletal and dental effects of two treatment methods - SEFA III and SEA III for growing patients from 9 to 14 years age group with upper and lower jaw growth differences  
Scientific Title of Study   Comparison of two treatment protocols - SEFA III and SEA III for developing dentoskeletal Class III correction - an institutional based randomized clinical study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Chelsia G Kulathinal 
Designation  Junior Resident 
Affiliation  Government Dental College Calicut 
Address  Room no.21 PG Clinic Department of Orthodontics Government Dental College Calicut Pin 673008

Kozhikode
KERALA
673008
India 
Phone  9496663441  
Fax    
Email  kulathinalchelsiag@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Praveen S 
Designation  Professor 
Affiliation  Government Dental College Calicut 
Address  Room no.21 PG Clinic Department of Orthodontics Government Dental College Calicut Pin 673008

Kozhikode
KERALA
673008
India 
Phone  9846274491  
Fax    
Email  orthonair@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Praveen S 
Designation  Professor 
Affiliation  Government Dental College Calicut 
Address  Room no.21 PG Clinic Department of Orthodontics Government Dental College Calicut Pin 673008

Kozhikode
KERALA
673008
India 
Phone  9846274491  
Fax    
Email  orthonair@gmail.com  
 
Source of Monetary or Material Support  
Government Dental College Kozhkode,Government Medical College Campus,Kozhikode,Kerala 673008 
 
Primary Sponsor  
Name  Chelsia G Kulathinal 
Address  Room no.21 PG Clinic Department of Orthodontics Government Dental College Calicut Pin 673008 
Type of Sponsor  Other [PRINCIPAL INVESTIGATOR] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Chelsia G Kulathinal  Government Dental College Calicut  Room no.21 PG Clinic Department of Orthodontics Government Dental College Calicut Pin 673008
Kozhikode
KERALA 
9496663441

kulathinalchelsiag@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee,Government Dental College,Kozhikode  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K088||Other specified disorders of teethand supporting structures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  SEA III -Splints,Class III elastics,Alternate Rapid Maxillary Expansion and Constriction  SEFA III is compared with a modified protocol including only intra oral components namely, Fixed maxillary splint ,removable mandibular splint,class III extra oral elastics,Alternate Rapid Maxillary expansion and constriction for loosening of mid palatal suture and expanding and advancing of maxilla 
Comparator Agent  SEFA III including Splints,class III elastics,Alternate Rapid Maxillary Expansion and Constriction and facemak  For correcting Class III,already existing treatment SEFA III appliance including following components are given.Fixed maxillary splint,removable mandibular splint,Class III elastics,Alternate Rapid maxillary expansion and constriction for loosening of midpalatal suture and expanding maxilla.Facemask is also given 14-16 hrs 
 
Inclusion Criteria  
Age From  9.00 Year(s)
Age To  14.00 Year(s)
Gender  Both 
Details  1)Deciduous or Mixed dentition
2)Angle’s Class III Molar relationship
3)Anterior Cross bite / Edge to edge
4)Wits appraisal of less than or equal to 2.0 mm and ANB less than or equal to 3 degrees
5) Skeletal maturation CS3 stage 
 
ExclusionCriteria 
Details  1) Craniofacial malformations and/or syndromes
2)Previous orthopedic/orthodontic treatments. 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
primary outcome measures the skeletal and dental dimensional changes in Class III patients following SEFA III
protocol and a group of patients who had undergone SEA III protocol using conventional
cephalometric analyses, standard reference points and planes in 1 year. 
secondary outcome mesures the skeletal and dental dimensional changes in Class III patients following SEFA III
protocol and a group of patients who had undergone SEA III protocol using conventional
cephalometric analyses, standard reference points and planes at baseline(T1) and after 1 year(T2)  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the soft tissue dimensional changes in Class III patients following SEFA III
protocol and a group of patients who had undergone SEA III protocol using conventional
cephalometric analyses, standard reference points and planes. 
1 year 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/06/2025 
Date of Study Completion (India) 01/12/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Dentoskeletal class III malocclusion is characterized as increased growth of lower jaw or deficient growth of upper jaw or the combination. Most of the cases, the malocclusion is  accompanied by dental compensations. The objective of this study is to compare the effectiveness of two treatment protocols- SEA III (involving only intra oral appliances) and SEFA III (involves intra oral and extra oral appliances).The research will be conducted in the Department of Orthodontics and Dentofacial Orthopedics at Government Dental College, Kozhikode.

This study is a randomized double blind, parallel group trial comparing efficacy of two treatment protocols for treating developing dentoskeletal class III corrections - SEA III and SEFA III.SEA III includes maxillary and mandibular splints, class III elastics, Alternate Rapid Maxillary Expansion and Constriction for 7 weeks. SEFA III protocol includes maxillary and mandibular splints, class III extra oral elastics, Alternate Rapid Maxillary Expansion and Constriction for 7 weeks and facemask for 14 - 16 hours. Primary outcomes are skeletal and dental dimensional changes in Class III patients following SEFA III protocol and a group of patients who had undergone SEA III protocol using conventional cephalometric analyses, standard reference points and planes at 1 year. Secondary outcomes are the soft tissue dimensional changes in Class III patients following SEFA III protocol and a group of patients who had undergone SEA III protocol using conventional cephalometric analyses, standard reference points and planes at 1 year. 

Data will be computerized, and statistical analysis will be conducted using the Statistical Package for Social Sciences software for Windows. Quantitative variables will be summarized as mean and standard deviation. A paired and unpaired T test will be employed to compare the values before and after treatment(p>0.05).

If a significant result is observed in the SEA III group, the integration of the treatment protocol involving intra oral appliance alone may be considered for the future.


 
Close